Fonte: Neuropsychopharmacology. Unidade: FMRP
Assuntos: MODELOS ANIMAIS DE DOENÇAS, HIPOCAMPO, ESQUIZOFRENIA
ABNT
KIEMES, Amanda et al. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology, v. 47, n. 3, p. 687-695, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41386-021-01213-0. Acesso em: 06 nov. 2024.APA
Kiemes, A., Gomes, F. V., Cash, D., Uliana, D. L., Simmons, C., Singh, N., et al. (2022). GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia. Neuropsychopharmacology, 47( 3), 687-695. doi:10.1038/s41386-021-01213-0NLM
Kiemes A, Gomes FV, Cash D, Uliana DL, Simmons C, Singh N, Vernon AC, Turkheimer F, Davies C, Stone JM, Grace AA, Modinos G. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia [Internet]. Neuropsychopharmacology. 2022 ; 47( 3): 687-695.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/s41386-021-01213-0Vancouver
Kiemes A, Gomes FV, Cash D, Uliana DL, Simmons C, Singh N, Vernon AC, Turkheimer F, Davies C, Stone JM, Grace AA, Modinos G. GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia [Internet]. Neuropsychopharmacology. 2022 ; 47( 3): 687-695.[citado 2024 nov. 06 ] Available from: https://doi.org/10.1038/s41386-021-01213-0